The IGNITE II CC: Engagement, Coordination, Demonstration, and Dissemination

IGNITE II CC：参与、协调、示范和传播

• 批准号: 10827791
• 负责人: Hrishikesh Chakraborty
• 金额: $ 351.09万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-05-01 至 2025-06-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10827791
• 关键词: Acceleration; Accountability; Address; Administrative Coordination; Amplifiers; Area; Case Report Form; ClinVar; Clinical; Clinical Research; Clinical Trials Data Monitoring Committees; Clinical Trials Design; Clinical Trials Network; Clinical effectiveness; Collaborations; Communication; Communities; Community Medicine; Consent; Cost Effectiveness Analysis; Creativeness; Data; Data Analyses; Data Collection; Data Management Resources; Data Sources; Databases; Discipline; Documentation; Effectiveness; Enrollment; Ensure; Environment; Fostering; Genomic medicine; Genomics; Goals; Information Technology; Infrastructure; Institution; Institutional Review Boards; International; Intervention; Intranet; Knowledge; Leadership; Learning; Measures; Monitor; Office of Administrative Management; Online Systems; Ownership; Participant; Patient Recruitments; Positioning Attribute; Pragmatic clinical trial; Problem Solving; Productivity; Protocols documentation; Publications; Quality Control; Reporting; Research; Research Institute; Resources; Risk; Sample Size; Standardization; Statistical Data Interpretation; Structure; Time; Training; Translations; United States National Institutes of Health; Universities; Vision; Work; Writing; catalyst; clinical care; clinical practice; cost effective; dashboard; data interoperability; data management; data quality; data standards; database of Genotypes and Phenotypes; design; effective intervention; electronic data capture system; evidence base; experience; falls; flexibility; genome sciences; genomic data; implementation evaluation; implementation facilitation; implementation/effectiveness; improved; innovation; insight; knowledge base; knowledge hub; knowledge translation; leadership development; material transfer agreement; meetings; member; novel; phenotypic data; pragmatic implementation; precision medicine; programs; quality assurance; recruit; success; synergism; tool; translational genomics; trial design; uptake; working group

Achieving the necessary, robust and continually evolving evidence base for genomic medicine and its implementation in clinical practice requires overcoming many practical and logistical challenges. The Implementing GeNomics In pracTicE (IGNITE) Network has been and will continue to be strategic in identifying and disseminating solutions to these challenges. Specifically, we will continue to address the absence of supporting information technology infrastructure, lack of data standards and interoperability, and insufficient decision support. The effectiveness of IGNITE in achieving its objectives requires an experienced, and well- organized coordination center (CC) with strong existing ties to genomic medicine, that can recruit participants, create a vast resource of best practices for pragmatic clinical trials (PCTs), develop and deploy common measures and standards, identify solutions to challenges in implementation, develop a platform for data management and data analysis, and disseminate knowledge to the greater community. The proposed IGNITE II CC, a partnership between the Duke University Center for Applied Genomics and Precision Medicine and the Duke Clinical Research Institute, will provide a central resource for coordination, cost-effective PCT design, adaptation, oversight, and integration for the network. Importantly, we will leverage our successful leadership of the IGNITE I Administrative CC and our deep expertise in coordination of PCTs. The members of the CC have notable experience in each area required by the RFA as: 1) a demonstration project AND Administrative CC for IGNITE I, 2) CC for large networks and genomic medicine studies, and 3) CC for PCTs. The IGNITE II CC will provide strategic organizational leadership for the development of a novel, flexible, and adaptable genomic medicine PCT platform, enables seamless communication, sharing of information to optimize network productivity. The CC will ensure optimal and adaptable PCT design, participant recruitment, and data collection, develop a comprehensive analysis framework for evaluating the implementation and clinical effectiveness of the genomic medicine interventions, and help disseminate of knowledge beyond the network. In addition, the CC will innovate in 1) the implementation of pragmatic trial designs, electronic data capture (EDC) systems, and improved recruitment strategies, 2) institution of common measures across the network, 3) creative management of affiliates as a force amplifier for the network, 4) developing a Genomic Medicine Knowledge Base for dissemination, 4) creating a durable longitudinal data source from IGNITE participants and 5) developing a focus on sustainability. Our team's unparalleled track record of collaborative genomic medicine research and nationally recognized expertise in coordinating IGNITE I, large networks, and PCTs uniquely positions us to facilitate the completion of high-impact genomic medicine PCTs and advance the integration of genomic into clinical care.

实现必要的，强大的和不断发展的证据基础的基因组医学及其